1. Market Research
  2. > Pharmaceutical
  3. > Pathology Market Trends
  4. > Pathology Analysis & Statistics, July 2015 (p5)

Pathology Analysis & Statistics, July 2015 (p5)

24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Publishers

All regions

121-150 of about 7 300 reports

Purchase Reports From Reputable Market Research Publishers

2015 US Molecular Diagnostic Product Suppliers--Sales and Market Shares by Test

2015 US Molecular Diagnostic Product Suppliers--Sales and Market Shares by Test

  • $ 2 800
  • Industry report
  • July 2015
  • by Venture Planning Group

This unique report from VPGMarketResearch.com provides US Sales and market share estimates for major suppliers of molecular diagnostic products. The report also presents strategic assessments of majo ...

  • Industries : Pathology
  • Countries : United States
Global Prostate Cancer Devices Industry Report 2015

Global Prostate Cancer Devices Industry Report 2015

  • $ 2 800
  • Industry report
  • July 2015
  • by QY Research Group

Summary The Global Prostate Cancer Devices Industry Report 2015 is a professional and in-depth study on the current state of the Prostate Cancer Devices industry. The report provides a basic overview of ...

  • Industries : General Medicine and Specialty Medicine, Pathology
  • Countries : World
Global Diabetes Drug Therapy Industry Report 2015

Global Diabetes Drug Therapy Industry Report 2015

  • $ 2 800
  • Industry report
  • July 2015
  • by QY Research Group

Summary The Global Diabetes Drug Therapy Industry Report 2015 is a professional and in-depth study on the current state of the Diabetes Drug Therapy industry. The report provides a basic overview of the ...

  • Industries : Therapy
  • Countries : World
Global Cervical Cancer Drug Industry Report 2015

Global Cervical Cancer Drug Industry Report 2015

  • $ 2 800
  • Industry report
  • July 2015
  • by QY Research Group

Summary The Global Cervical Cancer Drug Industry Report 2015 is a professional and in-depth study on the current state of the Cervical Cancer Drug industry. The report provides a basic overview of the ...

  • Industries : General Medicine and Specialty Medicine, Pathology
  • Countries : World
Global Schizophrenia Drug Industry Report 2015

Global Schizophrenia Drug Industry Report 2015

  • $ 2 800
  • Industry report
  • July 2015
  • by QY Research Group

Summary The Global Schizophrenia Drug Industry Report 2015 is a professional and in-depth study on the current state of the Schizophrenia Drug industry. The report provides a basic overview of the industry ...

  • Industries : Pathology
  • Countries : World
Global Crohn’s Disease drug Industry Report 2015

Global Crohn’s Disease drug Industry Report 2015

  • $ 2 800
  • Industry report
  • July 2015
  • by QY Research Group

Summary The Global Crohn’s Disease drug Industry Report 2015 is a professional and in-depth study on the current state of the Crohn’s Disease drug industry. The report provides a basic overview of ...

  • Industries : Pathology
  • Countries : World
Hedgehog Signaling Pathway in Oncology Drug Pipeline Update 2015

Hedgehog Signaling Pathway in Oncology Drug Pipeline Update 2015

  • $ 3 139
  • Industry report
  • June 2015
  • by Bioseeker

Aberrant activation of the Hedgehog pathway has been associated with a number of human malignancies including carcinoma of lung, esophagus, pancreas and prostate. There are today 154 companies plus partners ...

  • Industries : Pathology
Prostate Cancer Drug Pipeline Update 2015

Prostate Cancer Drug Pipeline Update 2015

  • $ 3 139
  • Industry report
  • June 2015
  • by Bioseeker

Cancer of the prostate is the second most frequently diagnosed cancer in men in the US. The prostate cancer market is reaching maturity, and major players` sales have been eroded by the launch of various ...

  • Industries : Pathology
Pancreatic Cancer Drug Pipeline Update 2015

Pancreatic Cancer Drug Pipeline Update 2015

  • $ 3 139
  • Industry report
  • June 2015
  • by Bioseeker

There are today 336 companies plus partners developing 415 drugs targeting pancreatic cancer in development. In addition, there is 1 suspended drug and the accumulated number of ceased drugs over the last ...

  • Industries : Pathology
Targeting Focal Adhesion for the Treatment of Cancer Drug Pipeline Update 2015

Targeting Focal Adhesion for the Treatment of Cancer Drug Pipeline Update 2015

  • $ 3 139
  • Industry report
  • June 2015
  • by Bioseeker

Cell-matrix adhesions play essential roles in important biological processes including cell motility, cell proliferation, cell differentiation, regulation of gene expression and cell survival. At the ...

  • Industries : Pathology
Leukemia Drug Pipeline Update 2015

Leukemia Drug Pipeline Update 2015

  • $ 3 139
  • Industry report
  • June 2015
  • by Bioseeker

Leukemia includes a broad variety of histological separate disorders which make the leukemia market segmented. There are today 404 companies plus partners developing 533 leukemia drugs in 864 developmental ...

  • Industries : Pathology
Lung Cancer Drug Pipeline Update 2015

Lung Cancer Drug Pipeline Update 2015

  • $ 3 139
  • Industry report
  • June 2015
  • by Bioseeker

Non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC) comprises over 95% of all lung cancers. High unmet needs still persist for this tumor type and despite two decades of extensive R&D ...

  • Industries : Pathology
Viral Carcinogenesis Drug Pipeline Update 2015

Viral Carcinogenesis Drug Pipeline Update 2015

  • $ 3 139
  • Industry report
  • June 2015
  • by Bioseeker

There is a strong association between viruses and the development of human malignancies. We now know that at least six human viruses, Epstein-Barr virus (EBV), hepatitis B virus (HBV), hepatitis C virus ...

  • Industries : Pathology
Breast Cancer Drug Pipeline Update 2015

Breast Cancer Drug Pipeline Update 2015

  • $ 3 139
  • Industry report
  • June 2015
  • by Bioseeker

Breast cancer is the leading cause of cancer-related mortality among women worldwide. High unmet needs still persist for this tumor type. Despite recent drug approvals in the adjuvant and metastatic setting, ...

  • Industries : Pathology
Proteins in Oncology Drug Pipeline Update 2015

Proteins in Oncology Drug Pipeline Update 2015

  • $ 3 139
  • Industry report
  • June 2015
  • by Bioseeker

This drug pipeline update covers proteins, excluding antibodies, as drugs for the treatment of cancer. There are today 412 companies plus partners developing 457 protein drugs in 944 developmental projects ...

  • Industries : Pathology
TSH Signaling Pathway in Oncology Drug Pipeline Update 2015

TSH Signaling Pathway in Oncology Drug Pipeline Update 2015

  • $ 3 139
  • Industry report
  • June 2015
  • by Bioseeker

Human thyroid stimulating hormone (TSH) exerts its action through various signaling cascades such as cAMP cascade and the phospholipase C beta-mediated inositol phosphate generation. Further, it will give ...

  • Industries : Pathology
GnRH Signaling Pathway in Oncology Drug Pipeline Update 2015

GnRH Signaling Pathway in Oncology Drug Pipeline Update 2015

  • $ 3 139
  • Industry report
  • June 2015
  • by Bioseeker

Gonadotropin-releasing hormone (GnRH) secretion from the hypothalamus acts upon its receptor in the anterior pituitary to regulate the production and release of the gonadotropins, LH and FSH. There are ...

  • Industries : Pathology
Notch Signaling Pathway in Oncology Drug Pipeline Update 2015

Notch Signaling Pathway in Oncology Drug Pipeline Update 2015

  • $ 3 139
  • Industry report
  • June 2015
  • by Bioseeker

Aberrant Notch signaling has been linked to a number of malignancies including leukemias, lymphomas and carcinomas of the breast, skin, lung, cervix and kidneys. There are today 309 companies plus partners ...

  • Industries : Pathology
Peptides in Oncology Drug Pipeline Update 2015

Peptides in Oncology Drug Pipeline Update 2015

  • $ 3 139
  • Industry report
  • June 2015
  • by Bioseeker

There are today 305 companies plus partners developing 292 peptide drugs in 780 developmental projects in cancer. In addition, there are 5 suspended drugs and the accumulated number of ceased drugs ove ...

  • Industries : Pathology
HIF-1 Signaling Pathway in Cancer Drug Pipeline Update 2015

HIF-1 Signaling Pathway in Cancer Drug Pipeline Update 2015

  • $ 3 139
  • Industry report
  • June 2015
  • by Bioseeker

Cancer cells are characterized by rapid proliferation and require adaptive metabolic responses to allow continued biosynthesis and cell growth in the setting of decreased oxygen (O(2)) and nutrient availability. ...

  • Industries : Pathology
TSLP Signaling Pathway in Oncology Drug Pipeline Update 2015

TSLP Signaling Pathway in Oncology Drug Pipeline Update 2015

  • $ 3 139
  • Industry report
  • June 2015
  • by Bioseeker

Thymic stromal lymphopoietin (TSLP) is an IL-7-like cytokine that play various roles in a broad spectrum of biological procedures. TSLP can be secreted by epithelial cells upon pathogen stimulation. TSLP ...

  • Industries : Pathology
Renal Cancer Drug Pipeline Update 2015

Renal Cancer Drug Pipeline Update 2015

  • $ 3 139
  • Industry report
  • June 2015
  • by Bioseeker

The high existing unmet need in the treatment of renal cancer is reflected by the poor prognosis of patients with advanced stage disease, five- year survival rates with existing cytokine therapy being ...

  • Industries : Pathology
Targeting Immune Checkpoints in Cancer Immunotherapy Drug Pipeline Update 2015

Targeting Immune Checkpoints in Cancer Immunotherapy Drug Pipeline Update 2015

  • $ 3 139
  • Industry report
  • June 2015
  • by Bioseeker

BioSeeker’s Targeting Immune Checkpoints in Cancer Immunotherapy: Drug Pipeline Update is the most up to date and comprehensive pipeline review and competitive assessment you can get on this hot and ...

  • Industries : Pathology
Transcriptional Misregulation in Cancer Drug Pipeline Update 2015

Transcriptional Misregulation in Cancer Drug Pipeline Update 2015

  • $ 3 139
  • Industry report
  • June 2015
  • by Bioseeker

There are today 272 companies plus partners developing 323 transcriptional misregulation targeting drugs in 1367 developmental projects in cancer. In addition, there are 5 suspended drugs and the accumulated ...

  • Industries : Pathology
Apoptosis in Oncology Drug Pipeline Update 2015

Apoptosis in Oncology Drug Pipeline Update 2015

  • $ 3 139
  • Industry report
  • June 2015
  • by Bioseeker

Cancer cells frequently and possibly invariably possess apoptotic defects. In this context, apoptotic pathways provide exciting molecular targets for new therapeutic agents to specifically promote apoptosis ...

  • Industries : Pathology
Colorectal Cancer Drug Pipeline Update 2015

Colorectal Cancer Drug Pipeline Update 2015

  • $ 3 139
  • Industry report
  • June 2015
  • by Bioseeker

Until a decade ago, 5FU/leucovorin formed the mainstay of colorectal cancer treatment but Camptosar and Eloxatin quickly established themselves as components of gold-standard therapy. The advent of Avastin ...

  • Industries : Pathology
Conjugated Drugs in Oncology Drug Pipeline Update 2015

Conjugated Drugs in Oncology Drug Pipeline Update 2015

  • $ 3 139
  • Industry report
  • June 2015
  • by Bioseeker

Among conjugated drugs in oncology, antibody-drug conjugates (ADCs) are by far getting the most attention as a new drug class. Owing to improved technology and appropriate targeting, the clinical application ...

  • Industries : Pathology
Antibodies in Oncology Drug Pipeline Update 2015

Antibodies in Oncology Drug Pipeline Update 2015

  • $ 3 139
  • Industry report
  • June 2015
  • by Bioseeker

The commercial and therapeutic success of antibodies like Rituxan, Avastin, and Erbitux will force the industry to look into the next generation of therapeutic antibodies, preparing themselves for the ...

  • Industries : Pathology
Kit Receptor Signaling Pathway in Oncology Drug Pipeline Update 2015

Kit Receptor Signaling Pathway in Oncology Drug Pipeline Update 2015

  • $ 3 139
  • Industry report
  • June 2015
  • by Bioseeker

The Kit receptor signaling pathway includes activation of PI 3-kinase, Src family kinases and PLC gamma. Activating mutations in the Kit receptor are associated with several human malignancies include ...

  • Industries : Pathology
Lymphoma Drug Pipeline Update 2015

Lymphoma Drug Pipeline Update 2015

  • $ 3 139
  • Industry report
  • June 2015
  • by Bioseeker

Lymphoma is a broad term encompassing a variety of cancers of the lymphatic system. There are today 339 companies plus partners developing 464 lymphoma drugs in 884 developmental projects in cancer. In ...

  • Industries : Pathology
About 64 000 reports

Download Unlimited Documents from Trusted Public Sources

Water Industry in Peru and Cameroon

  • August 2015
    113 pages
  • Water  

    Digestive Syste...  

    Drinking Water  

  • Peru  

    Cameroon  

View report >

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.